A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionfe3ad48592443272a14ad7574d9a241abd9e5316): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Recombinant DNA (rDNA) Technology Market Research Report 2024

img

Global Recombinant DNA (rDNA) Technology Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Recombinant DNA (rDNA) Technology Market Research Report 2024

According to MRAResearch’s new survey, global Recombinant DNA (rDNA) Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant DNA (rDNA) Technology market research.
Key companies engaged in the Recombinant DNA (rDNA) Technology industry include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company and Sanofi, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Recombinant DNA (rDNA) Technology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant DNA (rDNA) Technology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Recombinant DNA (rDNA) Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Segment by Type
Expression System
Cloning Vector

Segment by Application


Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Recombinant DNA (rDNA) Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2018-2033)
2.2 Recombinant DNA (rDNA) Technology Growth Trends by Region
2.2.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Size by Region (2018-2023)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2024-2033)
2.3 Recombinant DNA (rDNA) Technology Market Dynamics
2.3.1 Recombinant DNA (rDNA) Technology Industry Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2018-2023)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2022
3.5 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2018-2023)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2024-2033)
5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2018-2023)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2018-2033)
6.2 North America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2018-2033)
7.2 Europe Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2018-2033)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2018-2033)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2018-2033)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Detail
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Detail
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Detail
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Detail
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Detail
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Detail
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Detail
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Detail
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Detail
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Detail
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Detail
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Detail
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023)
11.15.5 Horizon Discovery Group PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Expression System
Table 3. Key Players of Cloning Vector
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Region (2018-2023)
Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Region (2024-2033)
Table 10. Recombinant DNA (rDNA) Technology Market Trends
Table 11. Recombinant DNA (rDNA) Technology Market Drivers
Table 12. Recombinant DNA (rDNA) Technology Market Challenges
Table 13. Recombinant DNA (rDNA) Technology Market Restraints
Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2018-2023)
Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2022)
Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
Table 21. Date of Enter into Recombinant DNA (rDNA) Technology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2018-2023)
Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2024-2033)
Table 27. Global Recombinant DNA (rDNA) Technology Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2018-2023)
Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2024-2033)
Table 31. North America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2024-2033) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Detail
Table 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 48. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
Table 49. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 51. Profacgen Company Detail
Table 52. Profacgen Business Overview
Table 53. Profacgen Recombinant DNA (rDNA) Technology Product
Table 54. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 55. Profacgen Recent Development
Table 56. Amgen Inc Company Detail
Table 57. Amgen Inc Business Overview
Table 58. Amgen Inc Recombinant DNA (rDNA) Technology Product
Table 59. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 60. Amgen Inc Recent Development
Table 61. Novartis AG Company Detail
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Recombinant DNA (rDNA) Technology Product
Table 64. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. GenScript Company Detail
Table 67. GenScript Business Overview
Table 68. GenScript Recombinant DNA (rDNA) Technology Product
Table 69. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 70. GenScript Recent Development
Table 71. Pfizer Inc Company Detail
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Recombinant DNA (rDNA) Technology Product
Table 74. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Novo Nordisk A/S Company Detail
Table 77. Novo Nordisk A/S Business Overview
Table 78. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
Table 79. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 80. Novo Nordisk A/S Recent Development
Table 81. Eli Lilly and Company Company Detail
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product
Table 84. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Sanofi Company Detail
Table 87. Sanofi Business Overview
Table 88. Sanofi Recombinant DNA (rDNA) Technology Product
Table 89. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Biocon Company Detail
Table 92. Biocon Business Overview
Table 93. Biocon Recombinant DNA (rDNA) Technology Product
Table 94. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 95. Biocon Recent Development
Table 96. GlaxoSmithKline plc Company Detail
Table 97. GlaxoSmithKline plc Business Overview
Table 98. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
Table 99. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 100. GlaxoSmithKline plc Recent Development
Table 101. New England Biolabs. Company Detail
Table 102. New England Biolabs. Business Overview
Table 103. New England Biolabs. Recombinant DNA (rDNA) Technology Product
Table 104. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 105. New England Biolabs. Recent Development
Table 106. Cibus Company Detail
Table 107. Cibus Business Overview
Table 108. Cibus Recombinant DNA (rDNA) Technology Product
Table 109. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 110. Cibus Recent Development
Table 111. Monsanto Company Company Detail
Table 112. Monsanto Company Business Overview
Table 113. Monsanto Company Recombinant DNA (rDNA) Technology Product
Table 114. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 115. Monsanto Company Recent Development
Table 116. Horizon Discovery Group PLC Company Detail
Table 117. Horizon Discovery Group PLC Business Overview
Table 118. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
Table 119. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2018-2023) & (US$ Million)
Table 120. Horizon Discovery Group PLC Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2022 VS 2033
Figure 3. Expression System Features
Figure 4. Cloning Vector Features
Figure 5. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2022 VS 2033
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic and Government Research Institutes Case Studies
Figure 9. Other Case Studies
Figure 10. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 11. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Recombinant DNA (rDNA) Technology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Region: 2022 VS 2033
Figure 14. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2022
Figure 15. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2022
Figure 17. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Recombinant DNA (rDNA) Technology Market Share by Country (2018-2033)
Figure 19. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2018-2033)
Figure 23. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2018-2033)
Figure 31. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2018-2033)
Figure 39. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2018-2033)
Figure 43. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 46. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 47. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 48. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 49. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 50. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 51. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 54. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 56. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 57. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 58. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 59. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed